Development of a Gastro-retentive Dosage Form of a New Promising Anti-tuberculosis Drug Macozinone

Development of a Gastro-retentive Dosage Form of a New Promising Anti-tuberculosis Drug Macozinone

Introduction. Due to increase in the frequency of detecting cases of tuberculosis caused by strains of mycobacteria with resistance not only to traditional, but also recently introduced into clinical circulation anti-tuberculosis drugs, it is urgent to search for and develop new drugs that can be ef...

ver descrição completa

Detalhes bibliográficos
Principais autores: V. G. Nesterenko, R. N. Bolgarin, B. A. Rudoy, D. K. Salakhetdinov, Yu. G. Kazaishvili, V. S. Scherbakova, N. A. Nikitina, Yu. V. Medvedev, E. N. Fisher, E. A. Malashenko, I. E. Shohin
Formato: Artigo
Idioma:Russian
Publicado em: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2021-08-01
coleção:Разработка и регистрация лекарственных средств
Assuntos:
tuberculosis
macozinone
gastro-retentive tablet
modified release
mucoadhesion
cyclodextrin
Acesso em linha:https://www.pharmjournal.ru/jour/article/view/999

Internet

https://www.pharmjournal.ru/jour/article/view/999

Registros relacionados